Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Bicycle Therapeutics PLC Sponsored ADR (BCYC) had Free Cash Flow per Share of $-1.67 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.63M |
|
$-50.33M |
|
-- |
|
$0.63M |
|
$55.19M |
|
$-54.56M |
|
$4.32M |
|
$-50.24M |
|
$-50.24M |
|
$-50.33M |
|
$-50.33M |
|
$-50.33M |
|
$-50.33M |
|
$-54.56M |
|
$-53.49M |
|
69.80M |
|
69.80M |
|
$-0.72 |
|
$-0.72 |
|
| Balance Sheet Financials | |
$575.24M |
|
$4.70M |
|
$31.34M |
|
$606.58M |
|
$47.63M |
|
-- |
|
$48.69M |
|
$96.32M |
|
$510.26M |
|
$510.25M |
|
$510.25M |
|
69.81M |
|
| Cash Flow Statement Financials | |
$-115.53M |
|
$-0.98M |
|
$-0.10M |
|
$628.72M |
|
$510.11M |
|
$-118.61M |
|
$13.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-8673.93% |
|
-8673.93% |
|
-- |
|
-7987.76% |
|
-8002.07% |
|
$-116.51M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.01 |
|
6784.91 |
|
-9.86% |
|
-9.86% |
|
-8.30% |
|
-9.86% |
|
$7.31 |
|
|
Free Cash Flow per Share |
$-1.67 |
$-1.66 |
|